Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | +3.97% | +9.51% | +13.16% |
May. 13 | Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Turnstone Biologics Corp. Announces Board Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 66.61M |
---|---|---|---|---|---|
Net income 2024 * | -80M | Net income 2025 * | -99M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.99
x | P/E ratio 2025 * |
-0.96
x | Employees | 82 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.17% |
1 day | +3.97% | ||
1 week | +9.51% | ||
Current month | +10.34% | ||
1 month | +5.88% | ||
3 months | -27.46% | ||
6 months | +6.27% | ||
Current year | +13.16% |
Managers | Title | Age | Since |
---|---|---|---|
Sammy Farah
CEO | Chief Executive Officer | 51 | 15-09-30 |
Venkat Ramanan
DFI | Director of Finance/CFO | 55 | 22-01-31 |
Vijay Chiruvolu
CTO | Chief Tech/Sci/R&D Officer | 62 | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rishi Gupta
BRD | Director/Board Member | 46 | 16-09-30 |
Robert Gould
BRD | Director/Board Member | 69 | 18-12-31 |
Sammy Farah
CEO | Chief Executive Officer | 51 | 15-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.32% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 2.88 | +2.49% | 216,951 |
24-06-04 | 2.81 | +4.46% | 193,862 |
24-06-03 | 2.69 | +3.07% | 165,875 |
24-05-31 | 2.61 | -0.76% | 150,911 |
24-05-30 | 2.63 | 0.00% | 84,656 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.16% | 66.61M | |
+0.99% | 91.72B | |
0.00% | 39.44B | |
-8.52% | 34.47B | |
+65.40% | 26.7B | |
-17.37% | 15.13B | |
-5.99% | 13.27B | |
-10.69% | 11.74B | |
-47.78% | 10.54B | |
+8.09% | 9.41B |
- Stock Market
- Equities
- TSBX Stock